Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.72 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.54 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.54 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.54 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.54 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.54 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.54 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.54 |
| ▸ | DGKA | P23743 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3038090 | 0.89 | DNM1 (0.68) | DNM1CHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL19945709 | 0.88 | DNM1 (0.62) | DNM1CHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL11668491 | 0.86 | DNM1 (0.66) | DNM1CHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL18995582 | 0.86 | DNM1 (0.61) | DNM1DGKAALDH1A1SMN1; SMN2THRB | |
| SCHEMBL8394873 | 0.86 | DNM1 (0.96) | DNM1CHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL12540745 | 0.84 | DNM1 (0.75) | DNM1CHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL1333132 | 0.84 | DNM1 (0.81) | DNM1CHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL65102 | 0.84 | DNM1 (0.53) | DNM1CHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL8398343 | 0.84 | DNM1 (1.00) | DNM1DGKAALDH1A1THRBNAAA | |
| SCHEMBL1825177 | 0.84 | DNM1 (1.00) | DNM1DGKAALDH1A1THRBNAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107698755-B | Cationic polymer and preparation method and application thereof | 四川大学 | 2021-03-30 | — | — | CN | claimed |
| EP-4223285-A2 | METHOD OF ENCAPSULATING A NUCLEIC ACID IN A LIPID NANOPARTICLE HOST | Novartis AG (CH) | 2023-08-09 | — | — | EP | disclosed |
| US-20230201141-A1 | FOOD SUPPLEMENT AND COMPOSITION COMPRISING CHOLINE BUTYRATE SALT AND/OR BUTYRYLCHOLINE | ABERGAVENNY NV (BE) | 2023-06-29 | — | — | US | disclosed |
| EP-3169309-B1 | METHOD OF ENCAPSULATING A NUCLEIC ACID IN A LIPID NANOPARTICLE HOST | NOVARTIS AG (CH) | 2023-05-10 | — | — | EP | disclosed |
| EP-4019506-A1 | LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS | Novartis AG (CH) | 2022-06-29 | — | — | EP | disclosed |
| US-11370872-B2 | Composition for pattern formation, and pattern-forming method | JSR CORPORATION (JP) | 2022-06-28 | — | — | US | disclosed |
| EP-3083579-B1 | LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS | NOVARTIS AG (CH) | 2022-01-26 | — | — | EP | disclosed |
| CN-108461637-B | Hybrid for polymer solar cell electron transport layer and preparation method thereof | 常州大学 | 2021-11-30 | — | — | CN | disclosed |
| US-11071784-B2 | Biodegradable lipids for the delivery of active agents | ALNYLAM PHARMACEUTICALS, INC. (US) | 2021-07-27 | — | — | US | disclosed |
| US-10995173-B2 | Composition and pattern-forming method | JSR CORPORATION (JP) | 2021-05-04 | — | — | US | disclosed |
| WO-1997016406-A1 | PHOTOSENSITIVE INTRAMOLECULAR ELECTRON TRANSFER COMPOUNDS | SPECTRA GROUP LIMITED, INC. (US) | 1997-05-09 | — | — | WO | disclosed |
| EP-0270701-B1 | PLANT GROWTH PROMOTION | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1992-03-11 | — | — | EP | disclosed |
| US-4929267-A | BENZYL ALKOXYETHYLDIMETHYLAMMONIUM HALIDES | MITSUBISHI GAS CHEMICAL COMPANY (JP) | 1990-05-29 | — | — | US | disclosed |
| EP-0270701-A1 | Plant growth promotion | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1988-06-15 | — | — | EP | disclosed |
| US-4672069-A | INCAPACITATING AGENTS IN MUNITIONS; QUATERNARY SALTS FOR CHEMICAL WAREFARE; LETHAL | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1987-06-09 | — | — | US | disclosed |
| US-4672122-A | INCAPACITATING AGENT; CHEMICAL WARFARE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1987-06-09 | — | — | US | disclosed |
| US-4340698-A | CHOLINE COMPOUND CATALYST | INTERNATIONALE OCTROOI MAATSCHAPPIJ "OCTROPA" B.V. (NL) | 1982-07-20 | — | — | US | disclosed |
| EP-0010805-B1 | POWDER COATING, PROCESS FOR THE PREPARATION THEREOF AND ARTICLES COATED THEREWITH | UNILEVER N.V. (NL) | 1982-02-10 | — | — | EP | disclosed |
| US-4297465-A | SAID CATALYST MADE FROM AN ALUMINUM TRIALKYL, A VANADIUM OR TITANIUM HALIDE, AND A 2-AMINO ALKYL CARBOXYLATE | EASTMAN KODAK COMPANY (US) | 1981-10-27 | — | — | US | disclosed |
| EP-0010805-A1 | Powder coating, process for the preparation thereof and articles coated therewith | UNILEVER N.V. (NL) | 1980-05-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230201141-A1 | FOOD SUPPLEMENT AND COMPOSITION COMPRISING CHOLINE BUTYRATE SALT AND/OR BUTYRYLCHOLINE | BCHE, SLC10A2, CHAT | DNM1 3623/4885CHRM2 189/4885CHRM4 103/4885 |
| US-11071784-B2 | Biodegradable lipids for the delivery of active agents | LIPA, APOB, CETP | DNM1 472/4885CHRM2 4616/4885CHRM4 4634/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.